SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,111,281. The last known price of Bitcoin is 71,086.72423286 USD and is down -3.89 over the last 24 hours. It is currently trading on 12779 active market(s) with $28,515,435,687.36 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Bitcoins steep selloff is driving attention, with traders pointing to leveraged long liquidations and broader risk-off pressure. The community is split between buying an oversold dip near technical support and expecting further declines if selling continues.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Phase 3 REGAL trial of GPS has reached the 80th event, and the company expects topline results this month, driving intense attention ahead of the AML data readout. Traders celebrated a sharp after-hours move and speculated about a data leak or short covering, while others cautioned that the trial remains blinded and its outcome is unknown.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MSCIs decision to remove Strategy from its indexes is fueling concerns about passive fund selling, while Bitcoins decline adds pressure to the stock. Traders debate whether the potential outflows are already priced in and whether the exclusion will materially weaken Strategys Bitcoin-linked financing model.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

A widespread Microsoft 365 outage disrupted Outlook, Teams, Copilot and other services, prompting complaints from users whose work was interrupted. Traders debated whether the prolonged disruption should pressure the stock, which held near flat-to-positive, while some speculated about a cyberattack without confirmation.

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 1.03439229 USD and is down -2.16 over the last 24 hours. It is currently trading on 1895 active market(s) with $1,786,076,895.36 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

XRP is sliding alongside a broader crypto selloff, with traders pointing to risk-off sentiment, inflation and rate-hike concerns, and leveraged liquidations. The steep decline has sparked debate over whether support will hold or losses will deepen, while some holders are buying the dip and others cite stalled regulatory progress and weak demand as reasons for caution.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Jensen Huangs resignation and Colette Kresss interim appointment have rattled NVDA shares, with traders also debating potential China chip-export scrutiny and the companys reliance on Huangs leadership. The community is split between buying the selloff on confidence in Nvidias AI business and avoiding the stock amid leadership and regulatory uncertainty.

Zcash (ZEC) is a cryptocurrency . Users are able to generate ZEC through the process of mining. Zcash has a current supply of 16,962,604.07029401. The last known price of Zcash is 956.58767703 USD and is down -2.92 over the last 24 hours. It is currently trading on 670 active market(s) with $828,877,374.43 traded over the last 24 hours. More information can be found at https://z.cash/.

Zcash

Zcashs sharp pullback after a major rally is dominating discussion, with traders debating whether it is a broader crypto-market correction and liquidation flush or a deeper breakdown. Some call the selloff an oversold buying opportunity, while bears point to lost support and continued selling.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candels planned prostate-cancer BLA filing has been pushed to mid-2027 amid FDA discussions and assay refinement, prompting a sharp selloff and criticism of managements communication and credibility. Some traders see the delay as a manufacturing and regulatory hurdle rather than a problem with the clinical data, while others remain concerned about execution and the longer wait.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is under pressure alongside Bitcoins slide and broader weakness in crypto-linked stocks, with traders highlighting fresh lows and arguing over whether the selloff has further to run or the shares are forming a base. Some also point to COINs underperformance versus Bitcoin and concerns about trading activity, while a smaller group sees an oversold bounce opportunity.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

BMNR is drawing attention amid weakness in Ethereum and broader crypto-linked stocks, with traders focused on its ETH-treasury exposure and the shares decline. The community is split between dip-buyers expecting a recovery and critics questioning Tom Lees strategy, company spending, transparency and buybacks.

statis crypto Watchlist

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Brief Consumer: Primer: Exide Industries (EXID IN) - Apr 2026 and more

In this briefing: Primer: Exide Industries (EXID IN) - Apr 2026 Primer: Lumax Auto Technologies (LMAX IN) - Apr 2026 Primer: Hume Industries (HUME MK) - Apr 2026 BWMX: 1Q Review: Core Stabilizing, Tupperware Deal Up Next, Reiterate Buy Primer: Asahi Broadcasting (9405 JP) - Apr 2026 1. Primer: Exide Industries (EXID IN) - Apr 2026 Exide Industries is India's largest lead-acid battery manufacturer, strategically pivoting towards lithium-ion (Li-ion) cell production to capitalize on the electric vehicle (EV) and renewable energy storage boom. The company is undertaking significant capital expenditure to establish a 12 GWh Li-ion cell manufacturing plant through its subsidiary, Exide Energy Solutions Ltd. (EESL), which presents a substantial long-term growth opportunity but also carries execution risk and is expected to suppress free cash flow in the near term. While maintaining a dominant position in the profitable lead-acid aftermarket, which provides stable cash flows, the company faces increasing competition in the emerging Li-ion space and margin pressures from raw material price volatility.

Brief India: Primer: Delta Manufacturing (DELTAMAG IN) - Apr 2026 and more

In this briefing: Primer: Delta Manufacturing (DELTAMAG IN) - Apr 2026 Primer: Zen Technologies (ZEN IN) - Apr 2026 Primer: Krishna Institute of Medical Sciences (KIMS IN) - Apr 2026 Higher Import Prices and Modest Export Rebound to Push CAD to 1% of GDP in FY27 Primer: Lumax Auto Technologies (LMAX IN) - Apr 2026 1. Primer: Delta Manufacturing (DELTAMAG IN) - Apr 2026 Delta Manufacturing is a prominent Indian manufacturer of hard and soft ferrite magnets with a secondary business in textiles, facing significant financial headwinds characterized by persistent net losses and declining revenues over the past three years. Despite the challenging financial performance, the company operates within the growing Indian ferrite magnet market, which is poised to benefit from government initiatives like 'Make in India' and the increasing demand from the automotive (especially EV) and consumer electronics sectors. Key challenges for the company include intense competition, negative profitability margins, and a high valuation relative to its book value and recent performance, indicating a high-risk profile for potential investors.

Brief India: Primer: Zen Technologies (ZEN IN) - Apr 2026 and more

In this briefing: Primer: Zen Technologies (ZEN IN) - Apr 2026 Primer: Krishna Institute of Medical Sciences (KIMS IN) - Apr 2026 Higher Import Prices and Modest Export Rebound to Push CAD to 1% of GDP in FY27 Primer: Lumax Auto Technologies (LMAX IN) - Apr 2026 Exencial Industry Tidings - 24-04-2026 1. Primer: Zen Technologies (ZEN IN) - Apr 2026 Zen Technologies is a key beneficiary of the Indian government's 'Make in India' initiative, capitalizing on the growing defense budget and the need for modernization. The company is a dominant player in the domestic defense simulation and training market, with a significant market share. The company is experiencing hyper-growth, with revenue and net income showing triple-digit compound annual growth over the last three years. This is supported by a robust and growing order book, providing strong revenue visibility. Despite impressive profitability growth, the company has reported negative operating and free cash flow in the most recent fiscal year, indicating potential pressure on working capital as it scales.

Brief Equities Bottom-Up: Primer: Zen Technologies (ZEN IN) - Apr 2026 and more

In this briefing: Primer: Zen Technologies (ZEN IN) - Apr 2026 Primer: Krishna Institute of Medical Sciences (KIMS IN) - Apr 2026 BQE: Landmark Year Completed; Revenue Up 61%, Adj. EBITDA Up 47% UFG: Uni-Fuels Announces Full Audited 2025 Financial Results Which Showed Strong Revenue Growth Above Our Expectations. Primer: Lumax Auto Technologies (LMAX IN) - Apr 2026 1. Primer: Zen Technologies (ZEN IN) - Apr 2026 Zen Technologies is a key beneficiary of the Indian government's 'Make in India' initiative, capitalizing on the growing defense budget and the need for modernization. The company is a dominant player in the domestic defense simulation and training market, with a significant market share. The company is experiencing hyper-growth, with revenue and net income showing triple-digit compound annual growth over the last three years. This is supported by a robust and growing order book, providing strong revenue visibility. Despite impressive profitability growth, the company has reported negative operating and free cash flow in the most recent fiscal year, indicating potential pressure on working capital as it scales.

Brief Growth Ideas: Primer: Krishna Institute of Medical Sciences (KIMS IN) - Apr 2026 and more

In this briefing: Primer: Krishna Institute of Medical Sciences (KIMS IN) - Apr 2026 X-Energy Inc. (XE): Nuclear Play Ignites, IPO Jumps 27% on Day One Legal Tech VP Of Cloud Operations On Evaluating Legal AI Tools Healthcare Company Associate GC On Where Legal AI Products Break Down Primer: Lumax Auto Technologies (LMAX IN) - Apr 2026 1. Primer: Krishna Institute of Medical Sciences (KIMS IN) - Apr 2026 Krishna Institute of Medical Sciences (KIMS) is a leading multi-specialty healthcare provider with a strong presence in Southern India, particularly in Andhra Pradesh and Telangana. The company is known for its affordable care model and a doctor-partnership model that fosters clinical excellence. KIMS is in a significant growth phase, expanding its bed capacity through both organic and inorganic routes. This expansion into new geographies like Maharashtra and Karnataka, and the addition of new specialties, are expected to be key future growth drivers. While the company has demonstrated a strong financial track record with consistent revenue growth and healthy profitability, it faces challenges related to the integration of newly acquired hospitals, which has led to some margin compression.

Brief Equities Bottom-Up: Primer: Krishna Institute of Medical Sciences (KIMS IN) - Apr 2026 and more

In this briefing: Primer: Krishna Institute of Medical Sciences (KIMS IN) - Apr 2026 BQE: Landmark Year Completed; Revenue Up 61%, Adj. EBITDA Up 47% UFG: Uni-Fuels Announces Full Audited 2025 Financial Results Which Showed Strong Revenue Growth Above Our Expectations. Primer: Lumax Auto Technologies (LMAX IN) - Apr 2026 FISH: Finishing Off a Strong 2025; Ready to Redeploy 1. Primer: Krishna Institute of Medical Sciences (KIMS IN) - Apr 2026 Krishna Institute of Medical Sciences (KIMS) is a leading multi-specialty healthcare provider with a strong presence in Southern India, particularly in Andhra Pradesh and Telangana. The company is known for its affordable care model and a doctor-partnership model that fosters clinical excellence. KIMS is in a significant growth phase, expanding its bed capacity through both organic and inorganic routes. This expansion into new geographies like Maharashtra and Karnataka, and the addition of new specialties, are expected to be key future growth drivers.

Brief India: Higher Import Prices and Modest Export Rebound to Push CAD to 1% of GDP in FY27 and more

In this briefing: Higher Import Prices and Modest Export Rebound to Push CAD to 1% of GDP in FY27 Primer: Lumax Auto Technologies (LMAX IN) - Apr 2026 Exencial Industry Tidings - 24-04-2026 Primer: Transrail Lighting (TRANSRAI IN) - Apr 2026 Primer: Aether Industries (AETHER IN) - Apr 2026 1. Higher Import Prices and Modest Export Rebound to Push CAD to 1% of GDP in FY27 Hurt by soaring US import tariffs in Aug'25-Mar'26, India's goods exports grew just 0.9% in FY26, while imports (bolstered by higher prices) grew 6.5%, widening the trade deficit to US$333bn. Services exports have continued strongly outpacing imports. For the year to Feb'26, services imports grew 4%, services exports +9.6% and the services-trade surplus widened 16% to US$214bn. With an incomes surplus of US$100bn+ likely, the CAD is likely to be 0.5-0.6% of CAD in FY26, widening to 1% of GDP in FY27 amid higher crude oil prices. 2. Primer: Lumax Auto Technologies (LMAX IN) - Apr 2026 Lumax Auto Technologies is strategically positioning itself as a key Tier-0.5 supplier by expanding its product portfolio into high-growth areas such as advanced plastics, mechatronics, and alternative fuel systems, supported by strong inorganic growth and global technology partnerships.

Brief India: Primer: Lumax Auto Technologies (LMAX IN) - Apr 2026 and more

In this briefing: Primer: Lumax Auto Technologies (LMAX IN) - Apr 2026 Exencial Industry Tidings - 24-04-2026 Primer: Transrail Lighting (TRANSRAI IN) - Apr 2026 Primer: Aether Industries (AETHER IN) - Apr 2026 How the Arms License Changes Apollo Micro Systems’ Business Model? 1. Primer: Lumax Auto Technologies (LMAX IN) - Apr 2026 Lumax Auto Technologies is strategically positioning itself as a key Tier-0.5 supplier by expanding its product portfolio into high-growth areas such as advanced plastics, mechatronics, and alternative fuel systems, supported by strong inorganic growth and global technology partnerships. The company is well-positioned to capitalize on the transition to electric vehicles (EVs), with approximately 40% of its current order book linked to EV platforms and a focus on developing EV-agnostic components that benefit from premiumization and lightweighting trends. A robust financial performance, characterized by strong revenue and profit growth, is underpinned by a healthy order book, operational efficiencies, and successful integration of acquisitions, providing a solid foundation for future expansion and achieving its ambitious 'NorthStar' strategic goals.

Lumax Auto Technologies Schedules Analyst and Investor Plant Visit in Pune

Lumax Auto Technologies Limited ( ($IN:LUMAXTECH) ) has provided an update. Lumax Auto Technologies has announced that PhillipCapital will host a p...

Lumax Auto Tech to Join Philip Capital Non-Deal Investor Roadshow in Mumbai

An announcement from Lumax Auto Technologies Limited ( ($IN:LUMAXTECH) ) is now available. Lumax Auto Technologies Limited has notified the stock e...

Lumax Auto Technologies Ltd. engages in the manufacture and trade of automotive components. Its products include two-wheeler chassis, electrical and electronics components, gear shifters, intake system, integrated plastic modules, and oxygen sensor. The company was founded on October 30, 1981 and is headquartered in Gurugram, India.

Current Price	2,298.40
Prev Close	2,345.00
Open	2,330.00
Dividend Yield	0.36%
50-Day Moving Average	2,007.35
Beta	N/A
Avg. Volume	186,514.68
PE Ratio	44.00

52-Week High	2,503.00
52-Week Low	1,221.20
Market Capitalization	156.15B
EPS (Annual)	40.91
Price to Book	11.36
Revenue Per Employee	4.22M

Feed

News

Sentiment

Fundamentals

Info

LUMAXTECH.NSE Fundamentals